Data For Human Health Management
Data generation is a natural by-product of developing diagnostic assays. The evolution of the healthcare market means a greater emphasis on personalised information to enable better treatment decisions, on knowing you have a disease before it becomes debilitating (prognostic) and self-care diagnostic products.
The data itself is now seen as a valuable asset which is of interest to a number of players such as pharmaceutical companies (to add value to new therapeutics), insurance companies (to evaluate disease/healthcare impact), doctors (to manage patients) and patients themselves (to enable better self-care).
Our business model incorporates many avenues for commercialisation of healthcare information on individuals, population groups and/or diseases, to predict and monitor disease progression and therapeutic efficacy.
